PATHWAY
RATE-LIMITING ENZYME
+ ACTIVATORS · − INHIBITORS
PAGE
Phosphofructokinase-1
+ AMP, F-2,6-BP · − ATP, citrate
Fructose-1,6-bisphosphatase
+ ATP, acetyl-CoA · − AMP, F-2,6-BP
Isocitrate dehydrogenase
+ ADP · − ATP, NADH
Glycogen synthase
+ G6P, insulin, cortisol · − epinephrine, glucagon
Glycogen phosphorylase
+ epinephrine, glucagon, AMP · − G6P, insulin, ATP
Glucose-6-phosphate dehydrogenase
+ NADP⁺ · − NADPH
Pyruvate dehydrogenase (not "rate-limiting" of a pathway but key gate)
+ NAD⁺, ADP, Ca²⁺, insulin · − acetyl-CoA, NADH, ATP
Carbamoyl phosphate synthetase II
+ ATP, PRPP · − UTP
Glutamine-PRPP amidotransferase
− AMP, IMP, GMP
Carbamoyl phosphate synthetase I
+ N-acetylglutamate
Acetyl-CoA carboxylase
+ insulin, citrate · − glucagon, palmitoyl-CoA
Carnitine acyltransferase I (CPT I)
− malonyl-CoA
HMG-CoA synthase
(↑ with glucagon, low insulin)
HMG-CoA reductase
+ insulin, thyroxine, estrogen · − glucagon, cholesterol, statins
Cholesterol 7α-hydroxylase
− bile acids
ALA synthase
− heme, glucose
Tyrosine hydroxylase
− catecholamines (feedback) · metyrosine
Cholesterol side-chain cleavage (desmolase, CYP11A1)
+ ACTH, LH (via StAR transport)
Endocrine link